{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:51:42Z","timestamp":1786978302426,"version":"build-2736575974"},"reference-count":72,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,6,3]],"date-time":"2018-06-03T00:00:00Z","timestamp":1527984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The ongoing opioid epidemic has claimed more than a quarter million Americans' lives over the past 15\u00a0years. The epidemic began with an escalation of prescription opioid deaths and has now evolved to include secondary waves of illicit heroin and fentanyl deaths, while the deaths due to prescription opioid overdoses are still increasing. In response, the Centers for Disease Control and Prevention (CDC) moved to limit opioid prescribing with the release of opioid prescribing guidelines for chronic noncancer pain in March 2016. The guidelines represent a logical and timely federal response to this growing crisis. However, CDC acknowledged that the evidence base linking opioid prescribing to opioid use disorders and overdose was grades 3 and 4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Motivated by the need to strengthen the evidence base, this review details limitations of the opioid safety studies cited in the CDC guidelines with a focus on methodological limitations related to internal and external validity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Internal validity concerns were related to poor confounding control, variable misclassification, selection bias, competing risks, and potential competing interventions. External validity concerns arose from the use of limited source populations, historical data (in a fast\u2010changing epidemic), and issues with handling of cancer and acute pain patients' data. We provide a nonexhaustive list of 7 recommendations to address these limitations in future opioid safety studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Strengthening the opioid safety evidence base will aid any future revisions of the CDC guidelines and enhance their prevention impact.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.4564","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T08:20:12Z","timestamp":1528100412000},"page":"4-12","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base"],"prefix":"10.1002","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-3912","authenticated-orcid":false,"given":"Shabbar I.","family":"Ranapurwala","sequence":"first","affiliation":[{"name":"Department of Epidemiology University of North Carolina at Chapel Hill  Chapel Hill NC USA"},{"name":"Injury Prevention Research Center University of North Carolina at Chapel Hill  Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Naumann","sequence":"additional","affiliation":[{"name":"Department of Epidemiology University of North Carolina at Chapel Hill  Chapel Hill NC USA"},{"name":"Injury Prevention Research Center University of North Carolina at Chapel Hill  Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Austin","sequence":"additional","affiliation":[{"name":"Injury Prevention Research Center University of North Carolina at Chapel Hill  Chapel Hill NC USA"},{"name":"Department of Maternal and Child Health University of North Carolina at Chapel Hill  Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabarun","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Department of Epidemiology University of North Carolina at Chapel Hill  Chapel Hill NC USA"},{"name":"Injury Prevention Research Center University of North Carolina at Chapel Hill  Chapel Hill NC USA"},{"name":"Eshelman School of Pharmacy University of North Carolina at Chapel Hill  Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Department of Epidemiology University of North Carolina at Chapel Hill  Chapel Hill NC USA"},{"name":"Injury Prevention Research Center University of North Carolina at Chapel Hill  Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,3]]},"reference":[{"issue":"43","key":"e_1_2_6_2_1","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers United States, 1999\u20102008","volume":"60","author":"Paulozzi LJ","year":"2011","journal-title":"MMWR"},{"issue":"26","key":"e_1_2_6_3_1","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users\u2014United States, 2002\u20102013","volume":"64","author":"Jones CM","year":"2015","journal-title":"MMWR"},{"key":"e_1_2_6_4_1","unstructured":"Substance Abuse and Mental Health Services Administration Results from the 2013 National Survey on Drug Use and Health: summary of national findings NSDUH Series H\u201048 HHS Publication No. (SMA) 14\u20134863. Rockville MD: Substance Abuse and Mental Health Services Administration 2014."},{"key":"e_1_2_6_5_1","unstructured":"Centers for Disease Control and Prevention.Annual surveillance report of drug\u2010related risks and outcomes\u2014United States 2017. Surveillance Special Report 1. Centers for Disease Control and Prevention U.S. Department of Health and Human Services. Published August 31 2017. Accessed December 12 2017 fromhttps:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2017%C2%ADcdc-drug-surveillance-report.pdf."},{"key":"e_1_2_6_6_1","unstructured":"Centers for Disease Control and Prevention.Multiple cause of death data. Atlanta GA: US Department of Health and Human Services Centers for Disease Control and Prevention.2016. Available from http:\/\/ wonder.cdc.gov\/mcd.html. Accessed January 6 2016."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6626a4"},{"issue":"10","key":"e_1_2_6_8_1","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010\u20102014","volume":"65","author":"Warner M","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_2_6_9_1","unstructured":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. (August 29 2013). The CBHSQ Report: A Day in the Life of Adolescents: Substance Use Facts Update. Rockville MD."},{"key":"e_1_2_6_10_1","unstructured":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. (June 10 2014). The CBHSQ Report: A Day in the Life of Young Adults: Substance Use Facts. Rockville MD."},{"issue":"1","key":"e_1_2_6_11_1","first-page":"1","article-title":"Guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell D","year":"2016","journal-title":"MMWR"},{"key":"e_1_2_6_12_1","unstructured":"North Carolina Medical Board.Policy for the use of opioids for the treatment of pain.January2017. Available fromhttp:\/\/www.ncmedboard.org\/resources\u2010information\/professional\u2010resources\/laws\u2010rules\u2010position\u2010statements\/position\u2010statements\/Policy_for_the_use_of_opiates_for_the_treatment_of_pain. Accessed January 30 2017."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12444"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anclin.2016.01.002"},{"key":"e_1_2_6_15_1","unstructured":"ChouR DeyoR DevineB HansenR SullivanS JarvikJ. G BlazinaI DanaT BougatsosC TurnerJ.The effectiveness and risks of long\u2010term opioid treatment of chronic pain. Evidence Report\/Technology Assessment No. 218. (Prepared by the Pacific Northwest Evidence\u2010based Practice Center under Contract No. 290\u20132012\u201000014\u2010I.) AHRQ Publication No. 14\u2010E005\u2010EF. Rockville MD: Agency for Healthcare Research and Quality; September2014.www.effectivehealthcare.ahrq.gov\/reports\/final.cfm."},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2008.09.009"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12378"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3965-4"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1982.00340230087016"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)90166-X"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.brs.0000186860.23078.a8"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2002.10435.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2005.05020.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.03.021"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-2-201001190-00006"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.05.020"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2010.00397.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.370"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.117"},{"issue":"1","key":"e_1_2_6_30_1","first-page":"e13","article-title":"Trends in opioid use and dosing among socio\u2010economically disadvantaged patients","volume":"5","author":"Gomes T","year":"2011","journal-title":"Open Med"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.09.003"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1204141"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01260.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12011"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.12711"},{"key":"e_1_2_6_36_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid rescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription","volume":"30","author":"Edlund MJ","year":"2014","journal-title":"Clin J Pain"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12480"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12907"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.03.040"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.11.007"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.8071"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2698"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000505"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000255"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-015-3199-4"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm324"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199901000-00008"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws412"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114131"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113025"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112451"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx077"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg231"},{"key":"e_1_2_6_54_1","unstructured":"US Food and Drug Administration.Data and methods for evaluating the impact of opioid formulations with properties designed to deter abuse in the postmarket setting. US FDA 2017: Docket number FDA\u20102017\u2010N\u20102903. Accessed August 7 2017 fromhttps:\/\/www.regulations.gov\/document?D=FDA\u20102017\u2010N\u20102903\u20100001"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.02.002"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31826a86ae"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.06.002"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2015.3.23893"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S108302"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.7789"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000676"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.07.024"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0038"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.12.006"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2014.03.130290"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2008.83"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn164"},{"key":"e_1_2_6_68_1","first-page":"553","volume-title":"Advances in Longitudinal Data Analysis","author":"Robins J","year":"2009"},{"issue":"2","key":"e_1_2_6_69_1","first-page":"756","article-title":"An introduction to g methods","volume":"46","author":"Naimi AI","year":"2017","journal-title":"Int J Epidemiol"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000355"},{"key":"e_1_2_6_71_1","volume-title":"Modern Epidemiology","author":"Greenland S","year":"2008"},{"key":"e_1_2_6_72_1","volume-title":"Modern Epidemiology","author":"Greenland S","year":"2008"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu149"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.4564","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.4564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T04:59:47Z","timestamp":1694667587000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.4564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,3]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1002\/pds.4564"],"URL":"https:\/\/doi.org\/10.1002\/pds.4564","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,3]]},"assertion":[{"value":"2017-12-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}